VATS Block for Uniportal Video-assisted Thoracoscopic Surgery

NCT ID: NCT03083080

Last Updated: 2017-03-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-27

Study Completion Date

2019-03-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Traditionally, video-assisted thoracic surgery is performed under general anesthesia with double-lumen endotracheal tube. However, the complications associated with this large tube as well as inhalation anesthetics are frequently reported. Therefore, currently there is a trend toward non-intubated anesthesia methods for video-assisted thoracic surgery, which includes thoracic epidural block, peripheral nerve block, local anesthesia, local combined with peripheral nerve block, etc. Thoracic epidural block demands a high technique, but still risks catastrophic neurological complications in case of accidental dural puncture. Local anesthesia, perhaps more straightforward, however may need supplemental analgesia during incision, which will inevitably interrupt surgery and negatively affect the patients. This study aims to apply ultrasound guidance during local anesthetic injection for local anesthesia-based video assisted thoracic surgery, which helps inject the local anesthetic into the key intercostal nerve plane to provide more specific and precise blockade, thus avoiding the chance of blind injection. At the same time, ultrasound guidance has the potential to reduce the risk of systemic toxicity, prolong the duration of analgesia postoperatively, and facilitates postoperative recovery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Efficacy and Safety of VATS Block

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

VATS block (ropivacaine + epinephrine)

VATS block is the peripheral nerve block for video-assisted thoracic surgery, whose injection is administered at the site of chest wall incision.

Group Type EXPERIMENTAL

VATS

Intervention Type PROCEDURE

VATS is the abbreviation of video-assisted thoracic surgery, which aims to minimize the wound for thoracic surgery and to enhance patient recovery after surgery

Ropivacaine

Intervention Type DRUG

30 mL 0.5% ropivacaine is used to achieve VATS block

Epinephrine

Intervention Type DRUG

1:400000 epinephrine is mixed with ropivacaine (local anesthetic) to reduce the risk of local anesthetic systemic toxicity

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VATS

VATS is the abbreviation of video-assisted thoracic surgery, which aims to minimize the wound for thoracic surgery and to enhance patient recovery after surgery

Intervention Type PROCEDURE

Ropivacaine

30 mL 0.5% ropivacaine is used to achieve VATS block

Intervention Type DRUG

Epinephrine

1:400000 epinephrine is mixed with ropivacaine (local anesthetic) to reduce the risk of local anesthetic systemic toxicity

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults younger than 80 years old and weighing between 50-90 kg are scheduled for one-port video assisted thoracic surgery .

Exclusion Criteria

* Anticipated difficult airway
* Obvious coagulation abnormality
* Psychiatric patients or drug addiction
* Emergency operation or patients with a full stomach
* Difficulty in language expression
* Allergic to local anesthetic, morphine, or NSAID
* BMI \> 35
* Pregnancy
* Respiratory insufficiency
* Severe pleural adhesion
* Need for pleurodesis
* Refuse patient-controlled analgesia
* Patients with a pacemaker
* Severe liver dysfunction (serum albumin\<25g/l or Child-Pugh score≧10)
* Severe kidney dysfunction (creatinine clearance\<30ml/min)
* Inflammatory bowel disease
* Congestive heart failure (NYHA II-IV)
* Confirmed ischemic heart disease, peripheral arterial disease and/or cerebral vascular disease
* Patients with a high intra-ocular pressure (e.g. glaucoma)
* Neurological symptoms over the ipsilateral upper part of the body
Minimum Eligible Age

20 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taipei Medical University WanFang Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jui-An Lin

Role: CONTACT

+886-2-29307930 ext. 2160

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201504056

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Application of Pericapsular Nerve Group (PENG) Block
NCT07078773 ACTIVE_NOT_RECRUITING NA